Track topics on Twitter Track topics that are important to you
Genomics firm CosmosID Inc. raised $6mm in its Series B financing led by the Applied Value Group.
CosmosID’s powerful diagnostic platform can identify some 20,000 microbes, based on an intricate understanding of microbial biomarkers.
ROCKVILLE, Md., Jan. 27, 2016 /PRNewswire/ -- CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-gen...
ROCKVILLE, Md., Feb. 3, 2016 /PRNewswire/ -- CosmosID, a leading genomic big data company, today announced a partnership with QIAGEN to launch its metagenomics analysis platform in QIAGEN's CLC Genomi...
Researchers at the University of Texas Medical Branch at Galveston have discovered strains of flesh-eating bacteria that could lead them to understand how toxins in the bacteria work. This c...
HILDEN, Germany and AARHUS, Denmark, February 2, 2016 /PRNewswire/ -- FDA centers and researchers gain access to QIAGEN's enhanced solutions for applications including microbial and microbiome analys...
ALACHUA, FL--(Marketwired - October 26, 2015) - CTD Holdings, Inc. (OTCQB: CTDH) today announced Dr. Rita Colwell, Distinguished University Professor, University of Maryland at College Park and Johns ...